🔎 Trials Near Me

Pradžia › Krono liga › Rhode Island

Krono liga klinikiniai tyrimai Rhode Island

12 tyrimai dėl Krono liga ieško dalyvių vietose Rhode Island.

Miestai Rhode Island

Oficialus tyrimo tekstas (anglų kalba)

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • University Gastroenterology - Providence - West River Street ( Site 5057), Providence
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • University Gastroenterology, Providence
Renkami dalyviai4 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06581328

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • University Gastroenterology, Providence
Renkami dalyviai2/3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07196722

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

  • University Gastroenterology Providence, Providence
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • University Gastroenterology, Providence
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • University Gastroenterology-Site Number: 8400103, Providence
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • University Gastroenterology - GI Alliance-Site Number: 8400103, Providence
Renkami dalyviai3 fazė
Amžius nuo 16 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • University Gastroenterology, Providence
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-09 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Gastroenterology Associates, Providence
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-07 · NCT05230173

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Rhode Island Hospital, Providence
Renkami dalyviai4 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-05-27 · NCT05781152

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Providence
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-03-12 · NCT07113522

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.